Successful rescue TNF-α blocking for
Case report
IRIS
Infliximab
Monoclonal anti-TNF-α antibody
mycobacterium genavense
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
received:
23
09
2023
revised:
04
04
2024
accepted:
05
04
2024
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
16
4
2024
Statut:
epublish
Résumé
Immune reconstitution inflammatory syndrome (IRIS) has been reported in immunocompromised patients with disseminated
Identifiants
pubmed: 38623247
doi: 10.1016/j.heliyon.2024.e29341
pii: S2405-8440(24)05372-6
pmc: PMC11016716
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e29341Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.